Literature DB >> 17582083

Heparin-induced thrombocytopenia associated with fondaparinux.

Theodore E Warkentin, Brian T Maurer, Richard H Aster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17582083     DOI： 10.1056/NEJMc070346

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  54 in total

1.  [Thromboembolism prophylaxis in trauma surgery: S3 guidelines and significance of the amendment for trauma surgeons].

Authors:  S Haas; S Siebenlist; C Waydhas; R Krauspe; U Stöckle
Journal:  Unfallchirurg       Date:  2010-11       Impact factor: 1.000

2.  Fondaparinux-associated heparin-induced thrombocytopenia.

Authors:  Micah Burch; Barry Cooper
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-01

3.  Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin.

Authors:  Amani Al-Rossaies; Khalid M Alkharfy; Fakhar Al-Ayoubi; Abdulkareem Al-Momen
Journal:  Int J Clin Pharm       Date:  2011-10-16

Review 4.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 5.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 6.  [Treatment of postoperative thrombosis].

Authors:  L-C Linke
Journal:  Orthopade       Date:  2009-09-06       Impact factor: 1.087

7.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

Review 8.  Heparin-induced thrombocytopenia.

Authors:  Gowthami M Arepally; Thomas L Ortel
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

Review 9.  Heparin-induced thrombocytopenia and cerebral venous sinus thrombosis: case report and literature review.

Authors:  Mark J Fesler; Michael H Creer; John M Richart; Randall Edgell; Necat Havlioglu; Gershom Norfleet; Salvador Cruz-Flores
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

10.  Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux.

Authors:  Kit L Cheng; Judith Brody; Craig E Warshall; Elaine M Sloand; Steven L Allen
Journal:  Leuk Res       Date:  2010-04       Impact factor: 3.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.